Cyclooxygenase-2 Expression in Hamster and Human Pancreatic Neoplasia
Open Access
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- A cyclooxygenase‐2 inhibitor, nimesulide, inhibits postinitiation phase of N‐nitrosobis(2‐oxopropyl)amine‐induced pancreatic carcinogenesis in hamstersInternational Journal of Cancer, 2003
- Selective Cyclooxygenase-2 Inhibitor Rofecoxib (Vioxx) Induces Expression of Cell Cycle Arrest Genes and Slows Tumor Growth in Human Pancreatic CancerJournal of Gastrointestinal Surgery, 2002
- The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNKJournal of Cancer Research and Clinical Oncology, 2002
- Association Between Nonsteroidal Anti-Inflammatory Drug Use and the Incidence of Pancreatic CancerJNCI: Journal of the National Cancer Institute, 2002
- Cyclooxygenase 2 Expression in Pancreatic Adenocarcinoma and Pancreatic Intraepithelial NeoplasiaAmerican Journal of Clinical Pathology, 2002
- Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugsCancer, 2002
- Pancreatic Intraepithelial NeoplasiaAmerican Journal of Surgical Pathology, 2001
- Neoplasms of the Ampulla of Vater with Concurrent Pancreatic Intraductal Neoplasia: A Histological and Molecular StudyLaboratory Investigation, 2001
- Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amineCarcinogenesis, 1990